News & Videos - Euronext Stocks - English - Page 2

Press Release O 2 Telefónica and Nokia roll out 5G standalone core on Amazon Web Services in the cloud Deployment represents first major commercial service for an existing operator to run its 5G core network on a hyperscaler’s public cloud. 8 May 2024 Espoo, Finland – O 2 Telefónica in Germany and Nokia announced today the deployment of 5G standalone core software on Amazon Web Services (AWS). The rollout provides O 2 Telefónica with ultra-low latency to deliver advanced 5G services, like...

ABIVAX Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 08-May-2024 / 08:30 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8,...

Amsterdam, 08 May 2024 - Azerion Group N.V. (“Azerion”) has today published the Notice of the Annual General Meeting 2024, which will be held on 20 June 2024 (the AGM). The Notice, Agenda and accompanying Explanatory Notes, as well as the 2023 Annual Report and other relevant documentations have been published on our website www.azerion.com/investors-bc/ . The Agenda of the AGM includes, amongst others, the proposal (i) to adopt the 2023 financial statements, (ii) to renew the appointment of...

Alstom FY 2023/24 Free cash flow at €(557) million following strong €562 million Free cash flow generation in the second half on the back of operational turnaround, and €2 billion deleveraging plan ready to be executed. Deleveraging plan now fully defined, Baa3 rating affirmed, and outlook will be changed to stable upon successful closing of the hybrid bond issuance and the rights issue Divestments ca. €700 million already announced Hybrid bond ca. €750 million with 50% Moody’s...

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 07 May 2024. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 27.8289 £ 24.9333 Estimated MTD return 0.62 % 0.64 % Estimated YTD return 1.02 % 1.48 % Estimated ITD return 178.29 % 149.33 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterdam...

Paris, France – May 8, 2024 CGG has signed a Memorandum of Understanding with Baker Hughes, an energy technology company, at the 2024 Offshore Technology Conference (OTC) in Houston to facilitate the parties exploring jointly offered carbon capture & storage (CCS) solutions. The collaboration and proposed commercial alliance intends to support the rapid increase of CCS projects that is underway by providing high-quality and fully integrated end-to-end solutions to screen, select, characterize...

May 8, 2024 Highlights Year-to-date Directional 1 revenue of US$871 million, in line with expectation Full year 2024 Directional revenue and Directional EBITDA guidance maintained Cash dividend of US$150 million (equivalent to EUR0.7651 per ordinary share) approved Share repurchase program of EUR65 million on track 20.7% completed 2 FPSO Sepetiba producing and on hire; FPSO Prosperity at full production capacity FPSO Jaguar contract award confirmed in April 2024, growing the backlog MoU with...

First quarter 2024 revenues increased by 31% to US$55.6 million, compared to the first quarter 2023, driven by the U.S. commercial launch of Joenja® and revenue growth of RUCONEST® RUCONEST® revenues increased by 8% to US$46.0 million, compared to the first quarter 2023 Joenja® (leniolisib) revenue of US$9.6 million, a 21% increase compared to the fourth quarter of 2023 On track for 2024 total revenue guidance of US$280 million - US$295 million (14 - 20% growth) Overall cash and marketable...

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Halle (Saale) / Munich, Germany, May 08, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that its 2024 Annual General Meeting will be held on Friday, June 21, 2024 at 01:00 p.m. (CEST) at the...

VusionGroup: English language version of 2023 Universal Registration Document now available VusionGroup (VU - FR0010282822) announced that the English language version of its 2023 Universal Registration Document is now available online at: https://www.actusnews.com/fr/telechargement/vusiongroup/2024/05/07/85743-vusiongroup_2023_urd_en.pdf Copies of the 2023 Universal Registration Document in English are available free of charge at VusionGroup's corporate headquarters, 55, place Nelson Mandela,...

ABIVAX Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents 07-May-2024 / 22:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Annual ordinary and extraordinary general meeting of May 30, 2024 Availability of the preparatory documents PARIS, France, May 7, 2024, 10:00PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“ Abivax...

Nokia Corporation Stock Exchange Release 07 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 07.05.2024 Espoo, Finland – On 07 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 376,202 3.48 CEUX - - BATE - - AQEU - - TQEX - - Total 376,202 3.48 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of...

EXEL Industries A French Société Anonyme with a share capital of €16,969,750 Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - France Reims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulation Date Total number of shares comprising the share capital Total number of voting rights April 30, 2024 6,787,900 Theoretical voting rights: 10,875,275 Exercisable voting rights*: 10,871,565 * After deduction of shares without...

Nanterre, 7 May 2024 Total number of voting rights and shares forming the share capital (Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority) __________________ Trading place : Euronext Paris Compartment : A ISIN code : FR0000121147 LEI code : 969500F0VMZLK2IULV85 Date Number of shares Total number of voting rights (theoretical) (1) 30 APRIL 2024 197,089,340 224,511,803 ( 1 ) In accordance with the provisions of...

EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT® Expansion in the oncology segment Development of Eurobio Scientific proprietary product portfolio Increase of international exposure Paris, 7 th May 2024 – 06:30 pm Eurobio Scientific (FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, announces the signing on May 7 th , 2024 of an agreement to...

Transaction in Own Shares 7 May, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 7 May, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 07/05/2024 587,067 £29.1200 £28.8750 £29.0111 LSE GBP...

PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) PATIENTS THIS PUBLICATION VALIDATES THE CLINICAL TRIAL DESIGN OF MASITINIB PHASE 2/3 STUDY AB10015 AND CONFIRMATORY STUDY IN ALS Paris, May 07, 2024, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced the publication of an article in Muscle &...

Amsterdam, 7 May 2024 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports first quarter 2024 revenue of $358 million, a 21% decrease versus the first quarter of 2023. First quarter 2024 adjusted EBITDA of $31 million decreased largely due to the decline in global metal prices compared to the prior period. Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “The first quarter 2024 adjusted EBITDA of $31 million is in...

ORAPI Date d'arrêté:30/04/2024 ARTICLE 223-16 du règlement général de l'AMF Actions du capital 6,643,534 Droits de vote théoriques (1) 6,725,429 Actions privées de droits de vote Autodétention au nominatif (2) 124,973 Autodétention au porteur * (3) 3,954 Autres * (4) 0 * à compléter par la société Droits de vote exerçables* 6,596,502 *= (1) - [(2) + (3) + (4)] Attachment DDV04_30042024...

Villers-lès-Nancy, 7 May 2024 - 6:00 p.m. (CET) PRESS RELEASE Q1 2024 revenue: €53.3 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment programme. The Divisions that sell equipment are heavily impacted by the economic context. 2024 outlook: after a phase of significant investment, the Group is targeting a return to growth beginning in H2. Q1 revenue (€m) 2023 reported basis 2024 reported basis Change / Reported basis - Ségur...